Closing Bell cover image

Alphabet Raises Capex Bar; What’s next for Software? 2/4/26

Closing Bell

00:00

Obesity drug split: Lilly outperforms Novo

Annika Kim-Constantino contrasts Lilly's strong demand and outlook with Novo Nordisk's sales concerns and decline.

Play episode from 29:03
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app